Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 55, Issue 7, Pages 2095-2101Publisher
SPRINGER
DOI: 10.1007/s10620-009-0954-6
Keywords
Alpha-fetoprotein; AFP-L3; DCP (des-gamma-carboxy prothrombin); Hepatocellular carcinoma; Prognostic factor
Categories
Funding
- Japan Society for the Promotion Science [16590582]
- Health, Labor and Welfare, Japan
- Grants-in-Aid for Scientific Research [16590582] Funding Source: KAKEN
Ask authors/readers for more resources
The aim of this study was to evaluate the clinical usefulness of measuring the Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3) for prognostic predictor in patients with hepatocellular carcinoma (HCC). A total of 477 HCC patients who underwent percutaneous ablative therapy or hepatectomy were enrolled. Overall survival and recurrence-free survival were respectively evaluated retrospectively and prospectively. Multivariate analyses of clinical prognostic factors were performed by Cox's stepwise proportional hazard model. AFP-L3 status was a statistically significant independent prognostic factor of long-term survival (P = 0.013) and recurrence-free survival (P = 0.006) in patients who underwent percutaneous ablative therapy. In contrast, AFP-L3 did not affect prognosis in patients who underwent hepatectomy. AFP-L3 had different impacts on prognosis in patients with HCC who underwent percutaneous ablative therapy and hepatectomy. Our results suggest that AFP-L3 positivity (a parts per thousand yen15%) might be a promising indicator for choosing therapeutic modalities in HCC patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available